Minoryx Therapeutics, S.L.
5 clinical trials · Sponsor
◉ Watch Minoryx Therapeutics, S.L.
| Record | Firm | Date |
|---|---|---|
| Disease Progression in Women With X-linked Adrenoleukodystrophy (NCT06178120) | Minoryx Therapeutics, S.L. | 2024-01-02 |
| A Clinical Study to Assess the Efficacy and Safety of Leriglitazone in Adult Male Subjects With Cerebral Adrenoleukodystrophy (NCT05819866) | Minoryx Therapeutics, S.L. | 2023-07-12 |
| A Clinical Study in Male Pediatric Patients With Cerebral X-linked Adrenoleukodystrophy (Cald) to Assess the Effects of MIN-102 Treatment on Disease Progression Prior to Human Stem Cell Transplant (HSCT) (NCT04528706) | Minoryx Therapeutics, S.L. | 2019-09-13 |
| A Clinical Study to Evaluate the Effect of MIN-102 on the Progression of Friedreich's Ataxia in Male and Female Patients (NCT03917225) | Minoryx Therapeutics, S.L. | 2019-03-26 |
| A Clinical Study to Evaluate the Efficacy and Safety of MIN-102 (IMP) in Male AMN Patients. (NCT03231878) | Minoryx Therapeutics, S.L. | 2017-12-08 |
Track Minoryx Therapeutics, S.L. automatically
Every clearance here is in the API, with alerts when new ones post.